Literature DB >> 12660393

Opioids and chronic neuropathic pain.

Kathleen M Foley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12660393     DOI： 10.1056/NEJMe030014

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  28 in total

1.  Analgesic effects of ketamine infusion therapy in korean patients with neuropathic pain: A 2-week, open-label, uncontrolled study.

Authors:  Jin Gu Kang; Chul Joong Lee; Tae Hyeong Kim; Woo Seok Sim; Byung Seop Shin; Sang Hyun Lee; Francis Sahngun Nahm; Pyung Bok Lee; Yong Chul Kim; Sang Chul Lee
Journal:  Curr Ther Res Clin Exp       Date:  2010-04

2.  Gaps and junctions between clinical experience and theoretical framework in the use of opioids.

Authors:  Marianne Kloke
Journal:  Support Care Cancer       Date:  2004-11       Impact factor: 3.603

3.  Treatment of pain in children after limb-sparing surgery: an institution's 26-year experience.

Authors:  Doralina L Anghelescu; Linda L Oakes; Gisele M Hankins
Journal:  Pain Manag Nurs       Date:  2010-09-20       Impact factor: 1.929

Review 4.  Pharmacologic management of chronic neuropathic pain: Review of the Canadian Pain Society consensus statement.

Authors:  Alex Mu; Erica Weinberg; Dwight E Moulin; Hance Clarke
Journal:  Can Fam Physician       Date:  2017-11       Impact factor: 3.275

Review 5.  The pharmacist's role in managing chronic opioid therapy.

Authors:  J Mark Wallace
Journal:  Curr Pain Headache Rep       Date:  2006-08

6.  Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society.

Authors:  D E Moulin; A J Clark; I Gilron; M A Ware; C P N Watson; B J Sessle; T Coderre; P K Morley-Forster; J Stinson; A Boulanger; P Peng; G A Finley; P Taenzer; P Squire; D Dion; A Cholkan; A Gilani; A Gordon; J Henry; R Jovey; M Lynch; A Mailis-Gagnon; A Panju; G B Rollman; A Velly
Journal:  Pain Res Manag       Date:  2007       Impact factor: 3.037

Review 7.  Neuropathic pain: a practical guide for the clinician.

Authors:  Ian Gilron; C Peter N Watson; Catherine M Cahill; Dwight E Moulin
Journal:  CMAJ       Date:  2006-08-01       Impact factor: 8.262

8.  Benzyl derivatives with in vitro binding affinity for human opioid and cannabinoid receptors from the fungus Eurotium repens.

Authors:  Jiangtao Gao; Francisco León; Mohamed M Radwan; Olivia R Dale; Afeef S Husni; Susan P Manly; Shari Lupien; Xiaoning Wang; Robert A Hill; Frank M Dugan; Horace G Cutler; Stephen J Cutler
Journal:  J Nat Prod       Date:  2011-06-13       Impact factor: 4.050

Review 9.  An evidence-based algorithm for the treatment of neuropathic pain.

Authors:  Nanna B Finnerup; Marit Otto; Troels S Jensen; Søren H Sindrup
Journal:  MedGenMed       Date:  2007-05-15

10.  Repeated treatment with the synthetic cannabinoid WIN 55,212-2 reduces both hyperalgesia and production of pronociceptive mediators in a rat model of neuropathic pain.

Authors:  B Costa; M Colleoni; S Conti; A E Trovato; M Bianchi; M L Sotgiu; G Giagnoni
Journal:  Br J Pharmacol       Date:  2003-12-08       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.